Literature DB >> 31971562

Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency.

Kasidet Hiranniramol1, Yuhao Chen1,2, Weijun Liu1,3, Xiaowei Wang1.   

Abstract

MOTIVATION: The development of clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) technology has provided a simple yet powerful system for targeted genome editing. In recent years, this system has been widely used for various gene editing applications. The CRISPR editing efficacy is mainly dependent on the single guide RNA (sgRNA), which guides Cas9 for genome cleavage. While there have been multiple attempts at improving sgRNA design, there is a pressing need for greater sgRNA potency and generalizability across various experimental conditions.
RESULTS: We employed a unique plasmid library expressed in human cells to quantify the potency of thousands of CRISPR/Cas9 sgRNAs. Differential sequence and structural features among the most and least potent sgRNAs were then used to train a machine learning algorithm for assay design. Comparative analysis indicates that our new algorithm outperforms existing CRISPR/Cas9 sgRNA design tools.
AVAILABILITY AND IMPLEMENTATION: The new sgRNA design tool is freely accessible as a web application, http://crispr.wustl.edu. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31971562      PMCID: PMC7203743          DOI: 10.1093/bioinformatics/btaa041

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  31 in total

1.  Genome-scale CRISPR-Cas9 knockout screening in human cells.

Authors:  Ophir Shalem; Neville E Sanjana; Ella Hartenian; Xi Shi; David A Scott; Tarjei Mikkelson; Dirk Heckl; Benjamin L Ebert; David E Root; John G Doench; Feng Zhang
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

2.  Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation.

Authors:  John G Doench; Ella Hartenian; Daniel B Graham; Zuzana Tothova; Mudra Hegde; Ian Smith; Meagan Sullender; Benjamin L Ebert; Ramnik J Xavier; David E Root
Journal:  Nat Biotechnol       Date:  2014-09-03       Impact factor: 54.908

3.  Rationally engineered Cas9 nucleases with improved specificity.

Authors:  Ian M Slaymaker; Linyi Gao; Bernd Zetsche; David A Scott; Winston X Yan; Feng Zhang
Journal:  Science       Date:  2015-12-01       Impact factor: 47.728

4.  DNA targeting specificity of RNA-guided Cas9 nucleases.

Authors:  Patrick D Hsu; David A Scott; Joshua A Weinstein; F Ann Ran; Silvana Konermann; Vineeta Agarwala; Yinqing Li; Eli J Fine; Xuebing Wu; Ophir Shalem; Thomas J Cradick; Luciano A Marraffini; Gang Bao; Feng Zhang
Journal:  Nat Biotechnol       Date:  2013-07-21       Impact factor: 54.908

5.  Sequence determinants of improved CRISPR sgRNA design.

Authors:  Han Xu; Tengfei Xiao; Chen-Hao Chen; Wei Li; Clifford A Meyer; Qiu Wu; Di Wu; Le Cong; Feng Zhang; Jun S Liu; Myles Brown; X Shirley Liu
Journal:  Genome Res       Date:  2015-06-10       Impact factor: 9.043

6.  Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications.

Authors:  Maurice Labuhn; Felix F Adams; Michelle Ng; Sabine Knoess; Axel Schambach; Emmanuelle M Charpentier; Adrian Schwarzer; Juan L Mateo; Jan-Henning Klusmann; Dirk Heckl
Journal:  Nucleic Acids Res       Date:  2018-02-16       Impact factor: 16.971

7.  Pairwise library screen systematically interrogates Staphylococcus aureus Cas9 specificity in human cells.

Authors:  Josh Tycko; Luis A Barrera; Nicholas C Huston; Ari E Friedland; Xuebing Wu; Jonathan S Gootenberg; Omar O Abudayyeh; Vic E Myer; Christopher J Wilson; Patrick D Hsu
Journal:  Nat Commun       Date:  2018-07-27       Impact factor: 14.919

8.  Increasing the specificity of CRISPR systems with engineered RNA secondary structures.

Authors:  D Dewran Kocak; Eric A Josephs; Vidit Bhandarkar; Shaunak S Adkar; Jennifer B Kwon; Charles A Gersbach
Journal:  Nat Biotechnol       Date:  2019-04-15       Impact factor: 54.908

9.  WU-CRISPR: characteristics of functional guide RNAs for the CRISPR/Cas9 system.

Authors:  Nathan Wong; Weijun Liu; Xiaowei Wang
Journal:  Genome Biol       Date:  2015-11-02       Impact factor: 13.583

10.  High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.

Authors:  Benjamin P Kleinstiver; Vikram Pattanayak; Michelle S Prew; Shengdar Q Tsai; Nhu T Nguyen; Zongli Zheng; J Keith Joung
Journal:  Nature       Date:  2016-01-06       Impact factor: 49.962

View more
  10 in total

1.  GuideMaker: Software to design CRISPR-Cas guide RNA pools in non-model genomes.

Authors:  Ravin Poudel; Lidimarie Trujillo Rodriguez; Christopher R Reisch; Adam R Rivers
Journal:  Gigascience       Date:  2022-04-01       Impact factor: 6.524

Review 2.  Enzyme-free targeted DNA demethylation using CRISPR-dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression.

Authors:  Daniel M Sapozhnikov; Moshe Szyf
Journal:  Nat Protoc       Date:  2022-10-07       Impact factor: 17.021

3.  CRISPR-Cas9 gRNA efficiency prediction: an overview of predictive tools and the role of deep learning.

Authors:  Vasileios Konstantakos; Anastasios Nentidis; Anastasia Krithara; Georgios Paliouras
Journal:  Nucleic Acids Res       Date:  2022-04-22       Impact factor: 19.160

Review 4.  Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.

Authors:  Muhammad Naeem; Saman Majeed; Mubasher Zahir Hoque; Irshad Ahmad
Journal:  Cells       Date:  2020-07-02       Impact factor: 6.600

Review 5.  Perspectives in primary hyperoxaluria - historical, current and future clinical interventions.

Authors:  Kevin Shee; Marshall L Stoller
Journal:  Nat Rev Urol       Date:  2021-12-08       Impact factor: 16.430

6.  CRISPRedict: a CRISPR-Cas9 web tool for interpretable efficiency predictions.

Authors:  Vasileios Konstantakos; Anastasios Nentidis; Anastasia Krithara; Georgios Paliouras
Journal:  Nucleic Acids Res       Date:  2022-06-07       Impact factor: 19.160

Review 7.  Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors.

Authors:  Dengyun Nie; Ting Guo; Miao Yue; Wenya Li; Xinyu Zong; Yinxing Zhu; Junxing Huang; Mei Lin
Journal:  Biomolecules       Date:  2022-09-05

Review 8.  New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer.

Authors:  Munazza Ahmed; Grace Hope Daoud; Asmaa Mohamed; Rania Harati
Journal:  Genes (Basel)       Date:  2021-05-12       Impact factor: 4.096

Review 9.  CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future.

Authors:  Fathema Uddin; Charles M Rudin; Triparna Sen
Journal:  Front Oncol       Date:  2020-08-07       Impact factor: 6.244

10.  dbGuide: a database of functionally validated guide RNAs for genome editing in human and mouse cells.

Authors:  Alexander A Gooden; Christine N Evans; Timothy P Sheets; Michelle E Clapp; Raj Chari
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.